ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 93868 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 93868; 2) Community: the network communities that were significantly associated with the response to NSC 93868; 3) Molecule: the relationships between components within communities and NSC 93868; 4) MDR: the compounds that were significantly associated with the NSC 93868.

NSC Compound Enrichment Correlation
NSC 281818 Ethanol, 2,2'-[[3-methyl-4-[[[4-[2-(4-propoxyphenyl]-4-thiazolyl]phenyl]imino]methyl]phenyl]imino]bis-, dimethanesulfonate (ester) 0.0395466756030208 -0.041699905
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0395466756030208 0.090199131
NSC 328410 Camptothecin Derivative 0.0395466756030208 0.016509471
NSC 328477 3'-Chloro-3-nitro-o-salicylotoluidide 0.0395466756030208 0.0077419178
NSC 606497 Camptothecin Derivative 0.0395466756030208 0.14701598
NSC 615534 Null 0.0395466756030208 0.075831809
NSC 626879 Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride 0.0395466756030208 -0.038380377
NSC 638409 (E)N-Ethyl-[3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl) prop-2-enoamide 0.0395466756030208 -0.018574435
NSC 639501 Cyclopentanone, 2-pentylidene-5-[(1-piperidinyl)methyl]- hydrochloride 0.0395466756030208 -0.081126941
NSC 63984 Cordycepin 0.0395466756030208 -0.048937421
Total:28  Current:21    [First] [Prev] [Next] [Last]